Immune Therapy Makes Headway Against a Lymphoma

THURSDAY, Sept. 8, 2016 — Genetically engineered immune cells appear capable of eradicating non-Hodgkin lymphoma when coupled with effective chemotherapy, a new early trial finds.
In this experimental therapy, white blood cells known as T-cells are…
Source: Topamax